Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population

The biological role of BMP-9 signaling in liver cancer remains dubious. To explore the potential use of BMP-9 signaling for anti-cancer therapy, we used recombinant human BMP-9, which we referred to as MB109, to study the effect on growth of fifteen hepatocellular carcinoma (HCC) cell lines. MB109 e...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Jung, Jae Woo, Yoon, So-Mi, Kim, Subin, Jeon, Yun-Hui, Yoon, Byung-Hak, Yang, Su-Geun, Kim, Min Kyoung, Choe, Senyon, Kuo, Mario Meng-Chiang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342011/
https://ncbi.nlm.nih.gov/pubmed/27650540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12062
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia